Veeva Systems announced Veeva Vault SiteExchange, a cloud application that allows life sciences companies, CROs and sites to easily access and exchange information during clinical trial execution. Veeva Vault SiteExchange streamlines collaboration among clinical teams for improved visibility across studies and increased operational efficiency to speed the research and development of new treatments.
Clinical investigators and sponsors regularly use manual paper-based processes and email to manage documents, which limits collaboration and transparency during clinical trials. These challenges lengthen trial timelines and often discourage investigators from participating in future clinical trials.
Veeva Vault SiteExchange improves collaboration and efficiency by consolidating all study document requests, workflows, notifications, and alerts across multiple trials in one place. Sponsors, CROs and investigator sites can establish an easy, consistent process for document access and exchange to reduce administrative burden. In addition, clinical teams have full visibility into the status of document requests across multiple clinical trials.
“The effective and timely management of documentation, information, and end-to-end processes is critical to the success of clinical trials,” said Jennifer Goldsmith, senior vice president of Veeva Vault strategy. “Veeva Vault SiteExchange fills a significant gap by creating a common way for sponsors, CROs, and sites to exchange information and accelerate the development and delivery of new treatments.”
Veeva Vault SiteExchange is available as the latest application in the Veeva Vault Clinical Suite, the most comprehensive suite of clinical applications on a single cloud platform to unify clinical data management and clinical operations. The announcement of Veeva Vault SiteExchange expands the Veeva Vault Clinical Suite to six applications, which also includes Vault EDC, Vault eSource, Vault CTMS, Vault eTMF and Vault Study Startup. The Veeva Vault Clinical Suite enables life sciences companies to seamlessly manage content and data across a clinical trial.
In other news, TransCelerate BioPharma, a nonprofit organization with membership comprised of global biopharmaceutical companies, selected Veeva Vault SiteExchange to simplify document access and exchange between investigators and sponsors through the Shared Investigator Platform (SIP), a platform that facilitates investigative site collaboration with multiple clinical trial sponsors.
The TransCelerate SIP Initiative aims to provide the industry with a centralized platform that will be interoperable with various clinical solutions, streamline communications between investigators and sponsors, and reduce redundant requests during a trial. TransCelerate chose Veeva Vault SiteExchange to simplify document access and exchange through the SIP. Veeva Vault SiteExchange will improve efficiencies and allow clinical trial investigators, sites, and participating sponsors to have immediate and centralized access to critical documents, eliminating one of the burdens that exists at investigator sites.
“Veeva is a proven technology innovator and cloud leader with an excellent track record in driving greater efficiency in clinical operations,” said Janice Chang, senior vice president of global operations at TransCelerate. “The integration of Veeva Vault SiteExchange with the Shared Investigator Platform further simplifies site administrative efforts, which is core to one of our strategic priorities to improve site experience.”
“TransCelerate is doing exciting work to promote enhanced industry collaboration and introduce efficient ways companies can accelerate treatments to market,” said Jennifer Goldsmith, senior vice president of Veeva Vault strategy. “We’re honored to work with TransCelerate and help clinical sites and sponsors effectively manage trial documentation to get medicine to patients more quickly.”
Veeva Vault SiteExchange is a cloud application that will help sites consolidate study document requests, alerts, and notifications across sponsors in the TransCelerate-sponsored SIP. Now investigators can spend less time on administrative tasks and focus more on clinical research.